EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, NanoVibronix's enterprise value is $-1.05 Mil.
NanoVibronix's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $2.28 Mil. Therefore, NanoVibronix's EV-to-Revenue for today is -0.46.
The historical rank and industry rank for NanoVibronix's EV-to-Revenue or its related term are showing as below:
NAOV'
s EV-to-Revenue Range Over the Past 10 Years
Min: -2.41 Med: 37.65 Max: 159.81
Current: -0.46
During the past 13 years, the highest EV-to-Revenue of NanoVibronix was 159.81. The lowest was -2.41. And the median was 37.65.
NAOV's EV-to-Revenue is ranked better than 97.7% of 825
companies
in the Medical Devices & Instruments industry
Industry Median: 2.97
vs NAOV: -0.46
As of today (2024-04-16), NanoVibronix's stock price is $0.7713.
NanoVibronix's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.26. Therefore, NanoVibronix's PS Ratio for today is 0.61.
NanoVibronix EV-to-Revenue Historical Data
The historical data trend for NanoVibronix's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
NanoVibronix Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
EV-to-Revenue
20.09
14.65
12.64
7.50
-0.41
NanoVibronix Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
EV-to-Revenue
7.50
5.09
8.53
-0.14
-0.41
Competitive Comparison
For the Medical Devices subindustry, NanoVibronix's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NanoVibronix EV-to-Revenue Distribution
For the Medical Devices & Instruments industry and Healthcare sector, NanoVibronix's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where NanoVibronix's EV-to-Revenue falls into.
NanoVibronix's current Enterprise Value is $-1.05 Mil.
NanoVibronix's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.28 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NanoVibronix's share price for today is $0.7713.
NanoVibronix's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.26.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NanoVibronix EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of NanoVibronix's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low frequency, low intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NAOV has been successfully added to your 